Table 1 Baseline characteristics of the study population
From: Relationship between glucocorticoids and viral load during the Omicron wave in mainland China
Variables | Covid-19 infected (n = 78) | Glucocorticoid used (n = 50) | Non-Glucocorticoid used (n = 28) | P value |
|---|---|---|---|---|
Age (years) | 74.5(17.5) | 76 (17) | 71.5 (22) | 0.889 |
Sex (male: female) | 49:29 | 33:17 | 16:12 | 0.437 |
Vaccination (vaccinated: unvaccinated) | 42:36 | 26:24 | 16:12 | 0.093 |
Phase of onset (early: convalescence: late) | 22:38:18 | 14:24:12 | 8:14:6 | 0.966 |
Underlying disease (n (%)) | ||||
COPD | 10 (12.8) | 8 (16) | 2 (7.1) | 0.262 |
Heart failure | 5 (6.4) | 2 (4) | 3 (10.7) | 0.245 |
Diabetic mellitus | 26 (33.3) | 19 (38) | 7 (25) | 0.243 |
Liver Cirrhosis | 4 (5.12) | 3(6) | 1 (3.6) | 0.641 |
Tumor | 8 (10.3) | 7 (14) | 1 (3.6) | 0.145 |
Chronic renal failure | 6 (7.7) | 5(10) | 1 (3.6) | 0.307 |
APACHE II score | 11 (5) | 11 (4) | 15(7) | 0.174 |
SOFA score | 1 (1) | 1 (1) | 1 (2) | 0.156 |